Uncrossed Fab binding to human Angiopoietin 2
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| D | Ig_2 | e4imkD3 | A: alpha bundles | X: Subtilisin-like | H: Subtilisin-like | T: Subtilisin-like | F: Ig_2 | ECOD (develop294) |
| C | Rhv | e4imkC1 | A: alpha bundles | X: HTH | H: HTH | T: winged helix domain | F: Rhv | ECOD (develop294) |
| A | RRM_1 | e4imkA1 | A: alpha bundles | X: beta-Grasp | H: HTH | T: winged helix domain | F: RRM_1 | ECOD (develop294) |
| B | Rhv | e4imkB1 | A: alpha bundles | X: HTH | H: HTH | T: winged helix domain | F: Rhv | ECOD (develop294) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| | Fab, anti-Ang2 | V-LAMBDA-C-KAPPA | Homo sapiens (human) | IGLV3-21*02, IGLJ1*01, IGKC*01 | V-DOMAIN V-LAMBDA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_V-LAMBDA-C-KAPPA | IMGT (202610-0) |
| | Fab, anti-Ang2 | VH-CH1 | Homo sapiens (human) | IGHV1-2*02, IGHJ3*02, IGHG1*01, IGHG1*02, IGHG1*04 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_V-LAMBDA-C-KAPPA | IMGT (202610-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Light Chain | IGLV3 | Lambda | - | SAbDab (2026-03-20) |
| | Heavy Chain | IGHV1 | - | - | SAbDab (2026-03-20) |
| Chain | Name | Target | Provenance Source |
|---|
| Vanucizumab | ANGPT2, VEGFA | Therapeutic SAbDab (2026-03-20) |
| Vanucizumab | ANGPT2, VEGFA | Therapeutic SAbDab (2026-03-20) |